DSM Sinochem Pharmaceuticals (DSP), the global leader in sustainable antibiotics, next generation statins and anti-fungals. We develop, produce and sell generic intermediates, active pharmaceutical ingredients (API) and drug products (DP).

Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the competition.

 

Headquartered in Singapore, we have manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico.

News

1 January, 2017

Mr. Lu Fang Bin to join DSM Sinochem Pharmaceuticals as Chief Strategy Officer and President China

Read more

2 December, 2016

DSM Sinochem Pharmaceuticals Joins the Pharmaceutical Supply Chain Initiative to Further Drive the Goals of the UN Industry Roadmap to Combat AMR

Read more

21 December, 2016

Dimitri de Vreeze to join Board of DSM Sinochem Pharmaceuticals

Read more

23 November, 2016

Change in Board Members as per February 2017

Read more

22 November, 2016

DSM Sinochem Pharmaceuticals Celebrates 15 Years of Green 7-ADCA Production

Read more

Copyright © 2017 DSM Sinochem Pharmaceuticals

Join the conversation

Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
DSM Sinochem Pharmaceuticals logo
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.